secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001161697-25-000142
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical CCO resigns; FY2025 revenue guidance reiterated at $38-39M
-----------------------------------------------------------------------

- Kenneth Miller resigned as Chief Commercial Officer effective April 3, 2025, to become CEO at a non-competing firm.
- Rob Cannon (VP of Sales, North America) will lead Core commercial operations until a permanent CCO is named.
- Company retained an executive search firm to find a new CCO.
- KORU Medical reaffirmed FY2025 revenue guidance of $38.0-$39.0 million, unchanged from March 12 call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000142/0001161697-25-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000142/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-25-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer